Search

Search Constraints

You searched for: Author/Creator Slifstein, Mark

Search Results

1. 3.3 DISTURBANCES IN NEURAL OSCILLATIONS, GLUTAMATE, AND GABA: EFFECTS OF KETAMINE AND COMPARISON TO SCHIZOPHRENIA. (1st April 2018)

3. A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia. (May 2016)

4. Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy. Issue 1 (30th April 2015)

8. Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres. Issue 2 (February 2019)

9. Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia. (23rd August 2021)

10. Dynamic shifts in brain network activation during supracapacity working memory task performance. Issue 4 (24th November 2014)